These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 35476961)
1. Adverse reactions following transfusion of blood components, with a focus on some rare reactions: Reports to the International Haemovigilance Network Database (ISTARE) in 2012-2016. Politis C; Wiersum-Osselton J; Richardson C; Grouzi E; Sandid I; Marano G; Goto N; Condeço J; Boudjedir K; Asariotou M; Politi L; Land K Transfus Clin Biol; 2022 Aug; 29(3):243-249. PubMed ID: 35476961 [TBL] [Abstract][Full Text] [Related]
2. The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results. Politis C; Wiersum JC; Richardson C; Robillard P; Jorgensen J; Renaudier P; Faber JC; Wood EM Vox Sang; 2016 Nov; 111(4):409-417. PubMed ID: 27658188 [TBL] [Abstract][Full Text] [Related]
3. Comparing transfusion reaction risks for various plasma products - an analysis of 7 years of ISTARE haemovigilance data. Saadah NH; van der Bom JG; Wiersum-Osselton JC; Richardson C; Middelburg RA; Politis C; Renaudier P; Robillard P; Schipperus MR Br J Haematol; 2018 Mar; 180(5):727-734. PubMed ID: 29318576 [TBL] [Abstract][Full Text] [Related]
4. Development of the Chinese Haemovigilance Network and reporting of adverse transfusion reactions from 2018 to 2020. Tian X; Kong Y; Wang J; He R; Li L; Liu Z; Vox Sang; 2022 Aug; 117(8):1027-1034. PubMed ID: 35560059 [TBL] [Abstract][Full Text] [Related]
5. Complications of blood donation reported to haemovigilance systems: analysis of eleven years of international surveillance. Wiersum-Osselton JC; Politis C; Richardson C; Goto N; Grouzi E; Marano G; Land KJ Vox Sang; 2021 Jul; 116(6):628-636. PubMed ID: 33278040 [TBL] [Abstract][Full Text] [Related]
6. First annual report of Chinese haemovigilance network. Yin Y; Tian X; Li L; Kong Y; Wang J; Lin F; Song N; Chen Q; Gan J; Peng T; Li X; Wu Y; Ge H; Wang H; Jiang J; Bai L; Ji H; Zhao G; Huang Y; Liu Z; Vox Sang; 2021 Jul; 116(6):718-724. PubMed ID: 33423307 [TBL] [Abstract][Full Text] [Related]
7. International haemovigilance: what have we learned and what do we need to do next? Wood EM; Ang AL; Bisht A; Bolton-Maggs PH; Bokhorst AG; Flesland O; Land K; Wiersum-Osselton JC; Schipperus MR; Tiberghien P; Whitaker BI Transfus Med; 2019 Aug; 29(4):221-230. PubMed ID: 30729612 [TBL] [Abstract][Full Text] [Related]
8. Transfusion-related adverse reactions: Data from the National Healthcare Safety Network Hemovigilance Module - United States, 2013-2018. Kracalik I; Mowla S; Basavaraju SV; Sapiano MRP Transfusion; 2021 May; 61(5):1424-1434. PubMed ID: 33880771 [TBL] [Abstract][Full Text] [Related]
9. The impact of revised definitions for transfusion-associated circulatory overload and transfusion-related acute lung injury on haemovigilance reporting. Yuan Y; Dennington PM; Daly J; Baidya S; Tung JP Vox Sang; 2023 Mar; 118(3):199-206. PubMed ID: 36654528 [TBL] [Abstract][Full Text] [Related]
10. A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data. Berg P; Heiden M; Müller S; Meyer B; Witzenhausen C; Ruppert-Seipp G; Kehr S; Funk MB Vox Sang; 2024 Sep; 119(9):953-962. PubMed ID: 38889998 [TBL] [Abstract][Full Text] [Related]
11. Acute blood transfusion reactions in a tertiary care hospital in Pakistan - an initiative towards haemovigilance. Borhany M; Anwar N; Tariq H; Fatima N; Arshad A; Naseer I; Shamsi T Transfus Med; 2019 Aug; 29(4):275-278. PubMed ID: 29845667 [TBL] [Abstract][Full Text] [Related]
12. Conference report: International Haemovigilance Seminar and the SHOT Annual Symposium, 10-12 July 2018. Bolton-Maggs PHB Transfus Med; 2019 Aug; 29(4):247-252. PubMed ID: 30592099 [TBL] [Abstract][Full Text] [Related]
13. Haemovigilance of reactions associated with red blood cell transfusion: comparison across 17 Countries. Rogers MA; Rohde JM; Blumberg N Vox Sang; 2016 Apr; 110(3):266-77. PubMed ID: 26689441 [TBL] [Abstract][Full Text] [Related]
14. The German Haemovigilance System--reports of serious adverse transfusion reactions between 1997 and 2007. Keller-Stanislawski B; Lohmann A; Günay S; Heiden M; Funk MB Transfus Med; 2009 Dec; 19(6):340-9. PubMed ID: 19725904 [TBL] [Abstract][Full Text] [Related]
15. Serious Hazards of Transfusion (SHOT) haemovigilance and progress is improving transfusion safety. Bolton-Maggs PH; Cohen H Br J Haematol; 2013 Nov; 163(3):303-14. PubMed ID: 24032719 [TBL] [Abstract][Full Text] [Related]
16. [Understanding and management of adverse transfusion reactions]. Yamada-Fujiwara M Rinsho Ketsueki; 2023; 64(9):925-931. PubMed ID: 37793867 [TBL] [Abstract][Full Text] [Related]
17. Review of haemovigilance at the Rabat Regional Blood Transfusion Centre in Morocco (2017-2021). Lemssahli I; Benajiba M; Belmekki A Pan Afr Med J; 2024; 47():60. PubMed ID: 38646139 [TBL] [Abstract][Full Text] [Related]
18. Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study. Wiersum-Osselton JC; Whitaker B; Grey S; Land K; Perez G; Rajbhandary S; Andrzejewski C; Bolton-Maggs P; Lucero H; Renaudier P; Robillard P; Santos M; Schipperus M Lancet Haematol; 2019 Jul; 6(7):e350-e358. PubMed ID: 31080132 [TBL] [Abstract][Full Text] [Related]
19. Serious hazards of transfusion - conference report: celebration of 20 years of UK haemovigilance. Bolton-Maggs PHB Transfus Med; 2017 Dec; 27(6):393-400. PubMed ID: 29282809 [TBL] [Abstract][Full Text] [Related]
20. Haemovigilance resources available for everyone: A report from the International Haemovigilance Tools Collaborative Project. Townsend M; Maryuningsih Soedarmono YS; Narayan S; Ashford P; Wood EM; Whitaker BI Vox Sang; 2024 Mar; 119(3):277-281. PubMed ID: 38126141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]